SEER

+ Watchlist + Portfolio

Seer, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $2.05
52-Week Range: $1.55 – $2.41
Market Cap: $111.85M
P/E (TTM): —
EPS (TTM): -1.22
Dividend Yield: —

Advanced Metrics

Price/Book: 0.49
PEG Ratio: —
Return on Equity: -26.45%
Return on Assets: -15.29%
Gross Margin: 47.70%
Operating Margin: -542.91%
Profit Margin: 0.00%
Current Ratio: 14.74
Debt/Equity: 0.10
Total Debt: $22.39M
Free Cash Flow: $-26.80M
Revenue Growth: -23.40%
Earnings Growth: —
Enterprise Value: $-16.95M

SEER Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$14.69M	$15.18M	$13.95M	$16.12M
Cost of Revenue	$8.40M	$8.15M	$7.12M	$8.11M
Gross Profit	$6.29M	$7.03M	$6.83M	$8.01M
Research & Development	$45.80M	$53.02M	$50.59M	$43.87M
Selling, General & Admin	$58.53M	$58.95M	$56.57M	$42.58M
Operating Expenses	$103.52M	$110.49M	$106.93M	$86.00M
Operating Income	-$97.23M	-$103.46M	-$100.10M	-$77.99M
EBITDA	-$93.29M	-$97.89M	-$93.92M	-$71.89M
Pretax Income	-$92.97M	-$86.28M	-$86.50M	-$73.40M
Income Tax	—	$0.00	$98.00K	$201.00K
Net Income	-$92.97M	-$86.28M	-$86.60M	-$73.60M
Diluted EPS	-1.49	-1.35	-1.39	-1.28
Diluted Shares	62.43M	63.85M	62.35M	57.45M

SEER Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$53.21M	$32.50M	$40.75M	$47.28M
Receivables	$7.02M	$6.72M	$6.23M	$5.95M
Inventory	$4.63M	$4.49M	$7.44M	$7.79M
Current Assets	$434.98M	$330.51M	$253.32M	$201.53M
Total Assets	$487.93M	$436.27M	$366.60M	$296.08M
Current Liabilities	$12.58M	$13.22M	$15.33M	$15.69M
Total Debt	$29.87M	$28.26M	$25.96M	$23.65M
Total Liabilities	$40.94M	$39.37M	$39.03M	$36.78M
Retained Earnings	-$219.50M	-$305.77M	-$392.37M	-$465.97M
Shareholders' Equity	$446.99M	$396.90M	$327.57M	$259.31M
Working Capital	$422.40M	$317.29M	$238.00M	$185.84M

SEER Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$60.78M	-$59.06M	-$46.11M	-$44.45M
Capital Expenditure	-$10.27M	-$7.31M	-$3.58M	-$1.80M
Free Cash Flow	-$71.05M	-$66.37M	-$49.69M	-$46.24M
Depreciation & Amortisation	$3.94M	$5.58M	$6.18M	$6.10M
Stock-Based Compensation	$33.67M	$34.42M	$28.21M	$15.41M
Investing Cash Flow	-$122.72M	$37.90M	$65.86M	$61.55M
Financing Cash Flow	$3.89M	$452.00K	-$11.49M	-$10.57M
Share Repurchases	-$20.00K	-$13.00K	-$11.82M	-$10.20M
Net Change in Cash	-$179.60M	-$20.71M	$8.25M	$6.53M

SEER Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$4.14M	$3.93M	$3.97M	$4.07M	$2.71M
Cost of Revenue	$2.14M	$1.94M	$2.01M	$2.02M	$1.81M
Gross Profit	$2.00M	$1.99M	$1.96M	$2.06M	$895.00K
Research & Development	$11.35M	$11.98M	$10.80M	$9.74M	$8.81M
Selling, General & Admin	$11.44M	$10.66M	$10.66M	$9.83M	$9.43M
Operating Expenses	$22.73M	$22.52M	$21.30M	$19.44M	$18.15M
Operating Income	-$20.73M	-$20.53M	-$19.35M	-$17.39M	-$17.26M
EBITDA	-$19.13M	-$18.99M	-$17.89M	-$15.88M	-$15.73M
Pretax Income	-$19.85M	-$19.38M	-$18.21M	-$15.97M	-$16.83M
Income Tax	$101.00K	$48.00K	$24.00K	$28.00K	$10.00K
Net Income	-$19.95M	-$19.42M	-$18.23M	-$15.99M	-$16.84M
Diluted EPS	-0.34	-0.33	-0.32	-0.29	-0.30
Diluted Shares	59.41M	58.09M	56.31M	56.02M	56.00M

SEER Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$52.45M	$37.93M	$44.97M	$47.28M	$47.32M
Receivables	$5.35M	$5.71M	$5.16M	$5.95M	$4.26M
Inventory	$7.07M	$7.51M	$8.13M	$7.79M	$8.08M
Current Assets	$255.27M	$225.64M	$214.36M	$201.53M	$181.59M
Total Assets	$347.26M	$322.49M	$308.61M	$296.08M	$272.13M
Current Liabilities	$13.20M	$11.79M	$15.04M	$15.69M	$10.24M
Total Debt	$25.40M	$24.83M	$24.25M	$23.65M	$23.03M
Total Liabilities	$36.26M	$34.20M	$36.79M	$36.78M	$30.65M
Retained Earnings	-$412.32M	-$431.74M	-$449.98M	-$465.97M	-$482.81M
Shareholders' Equity	$311.01M	$288.29M	$271.81M	$259.31M	$241.48M
Working Capital	$242.07M	$213.85M	$199.32M	$185.84M	$171.35M

SEER Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$11.42M	-$14.66M	-$7.57M	-$10.81M	-$15.44M
Capital Expenditure	-$654.00K	-$568.00K	-$283.00K	-$292.00K	-$270.00K
Free Cash Flow	-$12.07M	-$15.23M	-$7.85M	-$11.10M	-$15.71M
Depreciation & Amortisation	$1.60M	$1.54M	$1.46M	$1.51M	$1.53M
Stock-Based Compensation	$4.66M	$3.87M	$3.59M	$3.29M	$2.13M
Investing Cash Flow	$24.61M	$7.36M	$16.60M	$12.98M	$18.08M
Financing Cash Flow	-$1.50M	-$7.22M	-$1.99M	$143.00K	-$2.61M
Share Repurchases	-$675.00K	-$7.45M	-$2.01M	-$58.00K	-$2.62M
Net Change in Cash	$11.69M	-$14.51M	$7.04M	$2.31M	$33.00K

Market Snapshot

About

Seer, Inc. is a life sciences company developing a proteomics technology platform for unbiased biological discovery. The company engineered nanoparticle technology enables deep interrogation of the proteome to understand disease mechanisms and identify therapeutic targets. Seer serves pharmaceutical, biotechnology, and academic research organizations with proteomics solutions.